5 Key Takeaways
-
1
Analytical science is evolving in drug discovery due to the scale of data generated, enabling more informed decision-making.
-
2
The integration of AI and automated workflows allows researchers to evaluate more conditions and create larger datasets.
-
3
Complex and physiologically relevant models introduce variability, making it challenging to maintain consistent and reproducible data.
-
4
Simpler assays can provide valuable information and are often easier to scale and reproduce in early discovery stages.
-
5
Automation enhances the practicality of complex models by improving consistency, reducing variability, and allowing focus on data insights.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

About the Author(s)
James Strachan
Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.